2-Chloro-5-(5-ethoxycarbonyl-2-thenoyl)pyridine, 97.0%, 1g

4-(2-Aminoethyl)thiomorpholine 1,1-dioxide, 95.0%, 5g

Recipiente de cristalización ROTILABO® con pico, 20 ml, 40 mm, 10 Unidad(es)

3,5-Difluoropyridine-4-carboxylic acid, 97.0%, 25g

Propyl 2-Methylbutyrate>98.0%(GC)25mL

6-CHLORO-5-NITRO-1H-INDAZOLE, 95%, 100mg

3-Bromo-2-chloro-7-nitroquinoline, 98%, 1g

Diphenyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)phosphine oxide, 98%, 10g

Tert-butyl (R)-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benzo[e]indole-3-carboxylate, 97%, 1g

METHYL 5-FLUOROPIPERIDINE-3-CARBOXYLATE, 95.0%, 1g

(5-Methyl-4H-1,2,4-triazol-3-yl)methanamine hydrochloride, 97%, 1g

tert-Butyl (1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)carbamate, 95.0%, 250mg

1,2-Dimyristoyl-sn-glycerol, 98%, 1g